|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Operating activities | ||
| Net loss | ||
| Adjustments to reconcile net loss to cash used in operating activities: | ||
| Stock-based compensation expense | ||
| Depreciation and amortization | ||
| Noncash rent expense | ||
| Amortization of debt issuance costs, discounts and premiums | ||
| Change in fair value of compound derivative liability | ||
| Change in fair value of warrant liabilities | ||
| Change in fair value of earn-out liability | ||
| Amortization of premium (accretion of discount) on available-for-sale securities, net | ||
| Provision for excess and obsolete inventory | ||
| Provision for (recovery of) doubtful accounts | ||
| Cloud computing arrangement expenditures | ||
| Loss on extinguishment of debt, net | ||
| Loss on disposal of equipment | ||
| Loss on disposal of property and equipment | ||
| Paid-in-kind interest | ||
| Income tax benefit | ||
| Other | ||
| Changes in operating assets and liabilities: | ||
| Accounts receivable | ||
| Inventory | ||
| Deferred costs of services | ||
| Prepaid expenses and other current assets | ||
| Other long-term assets | ||
| Accounts payable | ||
| Deferred revenue | ||
| Accrued and other liabilities | ||
| Payment of paid-in-kind interest on extinguishment of debt | ||
| Net cash used in operating activities | ||
| Investing activities | ||
| Proceeds from sale of property and equipment | ||
| Palamedrix acquisition, net of cash acquired of $2,521 | ||
| Purchases of property and equipment, net of proceeds from sales | ||
| Purchases of available-for-sale securities | ||
| Proceeds from maturities of available-for-sale securities | ||
| Net cash provided by (used in) investing activities | ||
| Financing activities | ||
| Proceeds from exercise of stock options and employee stock purchase plan | ||
| Repayment of long-term debt | ||
| Proceeds from PIPE Investment, net of transaction costs | ||
| Proceeds from SPAC Merger, net of transaction costs | ||
| Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs | ||
| Proceeds from Paycheck Protection Program loan | ||
| Proceeds from SAFE agreement | ||
| Proceeds from exercise of stock options | ||
| Net cash provided by financing activities | ||
| Effect of exchange rates on cash, cash equivalents and restricted cash | ||
| Net (decrease) increase in cash, cash equivalents and restricted cash | ||
| Cash, cash equivalents and restricted cash at beginning of period | ||
| Cash, cash equivalents and restricted cash at end of period | ||
| Supplemental cash flow information: | ||
| Cash paid for interest | ||
| Supplemental disclosure of non-cash investing and financing activities: | ||
| Purchase of property and equipment included in accounts payable | ||
| Operating lease assets obtained in exchange for lease obligations | ||
| Issuance of Common Stock upon SPAC Merger | ||
| Contingent consideration payable for Palamedrix Acquisition | ||
| Surrender of shares in cashless exercise | ||
| Amendment fee related to extinguishment of debt financed through additional principal | ||
| Redeemable convertible preferred stock issued for debt prepayment penalty in connection with debt modification | ||
| Redeemable convertible preferred stock issued for prepayment of principal penalty in connection with debt modification | ||
| Redeemable convertible preferred stock issued for debt issuance costs in connection with debt modification | ||
| Redeemable convertible preferred stock issued for conversion of SAFE agreement | ||
| Redeemable convertible preferred stock issued for issuance costs | ||
| Redeemable convertible preferred stock issuance costs included in accounts payable | ||
| Issuance of Common Stock for services | ||
| Forgiveness of Paycheck Protection Program loan and accrued interest | ||
| Issuance of Common Stock for conversion of convertible debt | ||
| Reconciliation of cash, cash equivalents and restricted cash | ||
| Cash and cash equivalents | ||
| Restricted cash included in prepaid expenses and other current assets | ||
| Restricted cash included in other long-term assets |
Loading...
